Viatris Trading Volume Surges 496% to 222nd Position Despite Stock Decline

On May 30, 2025, Viatris (VTRS) experienced a significant trading volume of $737 million, marking a 496.13% increase from the previous day. This surge placed Viatris at the 222nd position in terms of trading volume for the day. However, despite the high trading volume, the stock price of Viatris declined by 0.45%.

Viatris Inc. is currently facing multiple class action lawsuits filed by shareholders who claim to have suffered losses due to alleged securities fraud. These lawsuits allege that the company and its executives provided misleading information to investors regarding the impact of a failed inspection at its Indore, India facility by the FDA. The defendants are accused of downplaying the significance of the FDA's warning letter, referring to it as a "minor headwind" for the company. The lawsuits claim that this misrepresentation led to a dramatic decline in the stock price on February 27, 2025, following the company's announcement of disappointing fiscal 2025 guidance.

The lawsuits seek to recover losses for shareholders who purchased Viatris securities during the class period from August 8, 2024, to February 26, 2025. The deadline for shareholders to register for these class actions is June 3, 2025. The lawsuits allege violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and shareholders are encouraged to contact the respective law firms to discuss their rights and potential recovery.